Sentences with phrase «over patient data»

Bitcoin Headlines — Coinbase to Charge Fees for On - Blockchain Transactions; Ethereum jetting ahead; Millions of Consumer Devices Vulnerable To Hacking Via Sound Waves; No Bitcoin Hard Fork please; Nasdaq is Helping Build a Blockchain Market for Ad Contracts; Google AI Firm's Blockchain Project for Hospitals Faces Concerns over Patient Data; Japanese Blockchain Consortium Exceeds 100 Members,...

Not exact matches

Approach a condition from the position of «Tell me what's bothering you» rather than «Tell me what you have,» Bertolini said, and you might convince a patient to hand over personal data in pursuit of a solution to what ultimately irks them.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Related Articles: Merck's Keytruda held back by docs who don't want to wait for diagnostics Bristol's Opdivo - Yervoy combo ups response rates in first - line lung cancer patients Roche's Tecentriq bursts onto immuno - oncology scene, with Merck and BMS in its sights Bristol - Myers» new Opdivo ad touts biomarker advantage over Merck's Keytruda Merck's Keytruda lines up its survival data for stepped - up battle with BMS» Opdivo

Technology is changing the patient - provider relationship as never before — starting with the obvious: Consumers now have access to — and, increasingly, control over their own healthcare data.

«Weight also appeared to be a factor associated with the rate of meniscal tears found at the time of surgery,» comments senior author, Philip Wilson, MD. «Our data demonstrates patient weight over 143 lbs (65 kg) to be associated with an increased rate of medial and lateral meniscal tears at the time of surgery.

Analyzing medical death rate data over an eight - year period, John Hopkins patient safety experts have calculated that more than 250,000 deaths per year are due to medical error in the United States.

This is the same company whose misuse of pseudonymised patient data, bought from the Health and Social Care Information Service, sparked the still - unresolved furore over the Government's care.data plans.

The researchers from the University of Exeter analysed clinical data from over 4,500 patients across the UK who were later diagnosed with bowel cancer.

Researchers looked at data on 74 300 patient who received metformin and sulfonylurea, another common diabetes drug, over a 25 - year study period.

It took us over two years to collect data on five patients.»

The registry, which is jointly maintained by the American College of Cardiology and the Society of Thoracic Surgeons, now contains data on over 50,000 patients whose TAVR procedures were performed at nearly 400 hospitals in the United States.

«In summary, these encouraging data build upon the real success of our translational efforts in myeloma over the last decade, and provide exciting new options with the real promise of improving patient outcome,» said Richardson, who is also the R.J. Corman professor at Harvard Medical School.

To improve on this method, Banerjee's team used clinical and embryo data from over 1600 IVF patients to identify the most influential factors determining whether a live birth will be achieved the second time around.

The researchers used data from the Parkinson's Progression Markers Initiative (PPMI), a large study sponsored by the Michael J. Fox Foundation that has been collecting information on recently diagnosed Parkinson's patients from over 30 different U.S. and international sites.

While in CT, the machine moves around the patient, the disk the researchers observed is rotating very slowly by itself meaning they had to take data over twelve years.

The National Cancer Institute is developing a platform to house data from the Cancer Genome Atlas — a massive catalog of genomic data from over 11,000 cancer patients.

Data from national and international surveys suggest that despite improvements over the last decade, significant proportions of patients have poor control of their elevated blood pressure.

Genotyping of a population of 329 patients with early RA revealed just over one - quarter had the allele * 2 HS1, 2 A enhancer, and one in 10 the allele * 1 HS1, 2 A enhancer, which is comparable with previously published data.7 Patients with the allele * 2 genotype had more active disease at the start of treatment and were significantly less likely to achieve a good response and / or remission after three months treatment than those patients with the allele * 1 gpatients with early RA revealed just over one - quarter had the allele * 2 HS1, 2 A enhancer, and one in 10 the allele * 1 HS1, 2 A enhancer, which is comparable with previously published data.7 Patients with the allele * 2 genotype had more active disease at the start of treatment and were significantly less likely to achieve a good response and / or remission after three months treatment than those patients with the allele * 1 gPatients with the allele * 2 genotype had more active disease at the start of treatment and were significantly less likely to achieve a good response and / or remission after three months treatment than those patients with the allele * 1 gpatients with the allele * 1 genotype.

The Bidens» wish list ranges from giving patients more control over their medical data to launching «a national conversation» about cancer drug pricing.

In one study that examined data from over 38 million inpatients in North America, Devereaux and his colleagues determined that patients treated at investor - owned, private for - profit hospitals had a significantly higher risk of dying.

Over time, patients end up providing a wealth of information to their health care providers, and when all our data are aggregated, they are also a boon to researchers studying trends in diseases and demographics for clues in how to better treat illness.

During a four - year period from 2013 - 2017, the researchers analyzed patient data from the Johns Hopkins electronic medical record system (Epic) of 487,104 black women ages 18 and over.

The study analyzed data regarding surgical outcomes — complications, serious complications, and mortality — in over 345,000 patients treated between 2009 and 2013 at academic hospitals throughout the United States.

To investigate, Vimal Derebail, MD, MPH (University of North Carolina at Chapel Hill / UNC Kidney Center) and his colleagues examined laboratory and clinical data over six months in 2011 concerning 5319 adult African - American hemodialysis patients.

The researchers analyzed data from 11,216 patients over the age of 66 with stage IV colorectal cancer from the Surveillance, Epidemiology, and End Results (SEER)- Medicare database.

The detection of mood states will improve over time as the software gets trained based on more conversations and data from more patients.

Dr. Zhang points out that the unique value of this study derives from the ability to perform longitudinal assessments of cognition in PD patients over a long time period and access to data from a large cohort that began when patients were in the earliest stage of disease.

«The next step will be to track a few patients over the course of their treatment, taking several blood draws to see if the data captured by the microfluidic device correlates with the data their medical team is collecting through other methods,» says Liu.

The team from the Arthritis Research UK Centre for Epidemiology looked at data from over 15,000 patients diagnosed with the disease who were being treated with certain types of immunosuppressive drugs, and found that one in five patients received no influenza vaccinations and one in two patients received no pneumonia vaccine over a five year follow - up period.

Using Medicare claims data for over 1.3 million patients aged 65 years and older from 2003 to 2013, the team analysed clinical process scores (a measure of whether or not a healthcare provider gives the recommended care to patients with a particular condition) and 30 day mortality data at each hospital.

To develop their predictive model, Dr. Miller and colleagues evaluated 57,588 patients in the National Trauma Data Bank over age 50 who had blunt trauma with isolated brain injury.

The researchers gathered patient data from all heart failure admissions over a two - year period at BMC.

To improve on this method, Banerjee's team used clinical and embryo data from over 1600 IVF patients to identify the most influential factors determining whether a live birth will be achieved the second...

These hospitals had data on between 50 and 387 cases each, making a total of over 6,000 patients, which was around 80 % of the total number of women being studied.

By tuning the model to replicate population data, such as the number of people at risk for developing TB and the fraction of TB patients who have drug resistance, the model can predict changes in the TB disease burden — or number of cases — over many years.

For the competition, participants were given just a slice of this data set, collected over 3 months, and asked to design an algorithm to predict how patients would fare in the subsequent 9 months, according to a standard functional scale that measures their ability to move and care for themselves.

A meta - analysis of data from over 6,500 patients has now shown that, although antidepressants are more effective than placebos, the difference is minor and varies according to the type of mental disorder.

Hopkins, UMMC and other hospitals collected $ 84 million over the three years ending in 2015 to treat acutely ill Baltimore asthma patients as inpatients or in emergency rooms, according to the news organizations» analysis of statewide hospital data.

The researchers collected data over eight years from 361 patients from patients with anorexia nervosa and related disorders, each of whom spent a week or more on an inpatient weight gain regimen.

Over the summer, I wrote a post emphasizing the importance of clinical sequence data sharing in repositories like the ClinSeq database, which has already proven life - saving (or life - changing) for thousands of patients and their families.

In collaboration with Dr. Josh Thaden and Vance Fowler, Duke University Medical Center, we are exploring relationships between bacterial genetic variation, emergence of AMR, and patient outcome in Enterobacter and Escherichia coli Bloodstream Infections (BSI) by leveraging the Duke University Bloodstream Infection Biorepository (BSIB), which contains robust clinical data, bacterial bloodstream isolates, and corresponding human sera and DNA from over 2000 patients with BSI caused by Gram - negative bacteria at Duke Hospital since 2002.

[21] In the recently presented FLAURA study, in which osimertinib was used in untreated patients with advanced EGFR - mutant NSCLC, the HR for systemic disease control and CNS control similarly favored osimertinib over erlotinib or gefitinib, supporting the preclinical data that showed osimertinib's penetration across the BBB and providing support for using this agent in first - line management of EGFR - mutant patients with brain metastases.

Dr. Ready said the crossover at progression could have influenced the survival data; in fact, an analysis of six patients who crossed over to sunitinib showed that tumors that had been growing either slowed their growth or shrank following crossover.

Results: Patient acceptance of the technology was strong: over 25,000 hours of passive monitoring data were collected.

The platform already includes data from several thousand patients and has over 300 users.

Among the important new findings was the high rate of regressions seen in over 40 % of patients, ranging in age of regression from 15 months to 16 years (unpublished data).

And I suspect over this next couple of years we're going to get more data about how that particular molecular signature for a given patient helps predict what their rate — the rate of their progression might be and therefore when it might be the appropriate time to go to transplant.

Data generated by the working group, which includes molecular profiling of over 10,000 tumors across 33 tumor types as well as a series of results on immune - tumor interaction and response mechanisms, will provide rich characterizations of the relationship between tumors and the immune microenvironment and its impact on patient outcomes.

City of Hope is home to diabetes experts from all over the world, who are studying genetic and epigenetic signatures in patients, using data from the most well - known, longest - ranging diabetes clinical trial.